NMRA Company Profile and Key Details

NASDAQ : NMRA

Neumora Therapeutics Common Stock

$3.20

-0.29-8.31%

At Close 4:00 PM

$3.05

−0.15-4.69%

After-Market 08:30 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Neumora Therapeutics, Inc. Common Stock (NMRA) stock declined over -8.31%, trading at $3.20 on NASDAQ, down from the previous close of $3.49. The stock opened at $2.96, fluctuating between $2.76 and $3.27 in the recent session.

Stock Snapshot

3.49

Prev. Close

534.69M

Market Cap

2.76

Day Low

-2.18

P/E Ratio

-1.47

EPS (TTM)

-2.78

Cash Flow per Share

2.96

Open

167.09M

Number of Shares

3.27

Day High

40.32%

Free Float in %

10.05

Book Value

1.96M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 02, 2026	2.85	3.27	2.76	3.20	1.96M
Feb 27, 2026	3.50	3.60	3.45	3.49	539.66K
Feb 26, 2026	3.50	3.59	3.37	3.55	379.72K
Feb 25, 2026	3.44	3.52	3.37	3.46	353.5K
Feb 24, 2026	3.45	3.56	3.35	3.43	829.76K
Feb 23, 2026	3.37	3.50	3.33	3.45	496.46K
Feb 20, 2026	3.48	3.49	3.34	3.39	719.37K
Feb 19, 2026	3.55	3.60	3.36	3.48	1.47M
Feb 18, 2026	3.50	3.65	3.41	3.59	1.33M
Feb 17, 2026	3.35	3.63	3.24	3.54	2.27M
Feb 13, 2026	3.30	3.35	3.14	3.20	3.7M
Feb 12, 2026	2.92	3.46	2.89	3.25	4.4M
Feb 11, 2026	2.93	3.02	2.77	3.00	2.07M
Feb 10, 2026	2.44	3.10	2.41	2.99	7.91M
Feb 09, 2026	2.11	2.50	2.09	2.39	2.04M
Feb 06, 2026	2.02	2.16	1.98	2.12	1.11M
Feb 05, 2026	1.98	2.04	1.92	1.96	796.4K
Feb 04, 2026	2.03	2.04	1.91	2.02	809.36K
Feb 03, 2026	1.97	2.06	1.95	2.04	344.16K
Feb 02, 2026	1.99	2.11	1.96	1.98	508.89K

Contact Details

Watertown, DE 02472

United States

https://www.neumoratx.com 857 760 0900

About Company

Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, which is in phase 3 clinical trials for the treatment of major depressive disorder. It also develops NMRA-511 that is in phase 1 clinical trials in patients with agitation associated with dementia due to Alzheimer's disease; and NMRA-266, which is in the phase 1 clinical trial for the treatment of schizophrenia and other neuropsychiatric disorders. In addition, its preclinical phase product includes NMRA-NMDA for the treatment of schizophrenia; NMRA-CK1d, a CK1d inhibitor program for the treatment of amyotrophic lateral sclerosis; NMRA-NLRP3 for the treatment of certain neurodegenerative conditions; and NMRA-GCase for the treatment of Parkinson's disease. The company was formerly known as RBNC Therapeutics, Inc. and changed its name to Neumora Therapeutics, Inc. in October 2021. Neumora Therapeutics, Inc. was incorporated in 2019 and is headquartered in Watertown, Massachusetts.

Stock Peers

REGN

9.14+1.17%

Regeneron Pharmaceuticals, Inc.$790.81 ARGX

-10.16-1.32%

argenx SE$756.76 UTHR

9.92+1.97%

United Therapeutics Corporation$513.82 VRTX

-10.8-2.17%

Vertex Pharmaceuticals Incorporated$486.03 MDGL

3.62+0.84%

Madrigal Pharmaceuticals, Inc.$435.62 PRAX

-6.16-1.83%

Praxis Precision Medicines, Inc.$330.59 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 ALNY

-7.85-2.36%

Alnylam Pharmaceuticals, Inc.$325.07 KRYS

-16.83-6.11%

Krystal Biotech, Inc.$258.81 ASND

8.59+3.68%

Ascendis Pharma A/S$242.09

Frequently Asked Questions

What is the current Neumora Therapeutics, Inc. Common Stock (NMRA) stock price?

Neumora Therapeutics, Inc. Common Stock (NASDAQ: NMRA) stock price is $3.20 in the last trading session. During the trading session, NMRA stock reached the peak price of $3.27 while $2.76 was the lowest point it dropped to. The percentage change in NMRA stock occurred in the recent session was -8.31% while the dollar amount for the price change in NMRA stock was - $0.29.

NMRA's industry and sector of operation?

The NASDAQ listed NMRA is part of Biotechnology industry that operates in the broader Healthcare sector. Neumora Therapeutics, Inc. Common Stock designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of NMRA?

No Data

How NMRA did perform over past 52-week?

NMRA's closing price is 423.73% higher than its 52-week low of $0.61 where as its distance from 52-week high of $3.65 is -12.33%.

How many employees does NMRA have?

Number of NMRA employees currently stands at 110.

Link for NMRA official website?

Official Website of NMRA is: https://www.neumoratx.com

How do I contact NMRA?

NMRA could be contacted at phone 857 760 0900 and can also be accessed through its website. NMRA operates from 490 Arsenal Way, Watertown, DE 02472, United States.

How many shares of NMRA are traded daily?

NMRA stock volume for the day was 1.96M shares. The average number of NMRA shares traded daily for last 3 months was 1.65M.

What is the market cap of NMRA currently?

The market value of NMRA currently stands at $534.69M with its latest stock price at $3.20 and 167.09M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	110
Beta	3.25
Sales or Revenue	N/A
5Y Sales Change%	0%
Fiscal Year Ends	N/A
Sector	Healthcare
Industry	Biotechnology

Employees	110
Beta	3.25
Sales or Revenue	N/A
5Y Sales Change%	0%
Fiscal Year Ends	N/A
Sector	Healthcare
Industry	Biotechnology

NMRA Company Profile and Key Details

Neumora Therapeutics Common Stock

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Company Overview

Earnings & Analyst Outlook

Shareholding & Insider Activity

Price Forecast & Outlook

Key Takeaways

Valuation Metrics